Smith & Nephew SNATS, Inc. (SNN) Covered Calls
Smith & Nephew (SNN) is a global medical technology company focused on the repair, regeneration, and replacement of soft and hard tissue. It provides an innovative portfolio of orthopaedic implants, sports medicine repair technologies, and advanced wound management solutions. Dedicated to helping patients restore mobility and improve quality of life, the company supports healthcare professionals globally with its "Life Unlimited" philosophy.
You can sell covered calls on Smith & Nephew SNATS, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SNN (prices last updated Thu 4:16 PM ET):
| Smith & Nephew SNATS, Inc. (SNN) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 32.34 | -0.59 | 30.54 | 33.89 | 709K | - | 22 |
| Covered Calls For Smith & Nephew SNATS, Inc. (SNN) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Mar 20 | 30 | 2.20 | 31.69 | -5.3% | -967.3% | |
| Apr 17 | 30 | 0.20 | 33.69 | -9.5% | -115.6% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Smith & Nephew plc operates as a portfolio medical technology company organized into three primary business units: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The Orthopaedics unit provides hip and knee replacement systems, trauma products, and robotics-assisted surgical technologies. The Sports Medicine & ENT segment focuses on minimally invasive surgery solutions for joint repair and ear, nose, and throat interventions. The Advanced Wound Management unit delivers specialized dressings, bioactives, and negative pressure therapy devices designed to treat complex wounds.
A core element of the firm's strategy is its integration of digital technologies and robotics, such as the CORI Surgical System, into procedural workflows. By providing a comprehensive range of implants, instruments, and software-driven surgical support, Smith & Nephew aims to improve clinical outcomes, reduce surgical variability, and support the shift toward outpatient procedures. The company maintains a strong global footprint, with significant R&D and manufacturing capacity dedicated to maintaining its leadership position in high-growth, technology-driven medical device markets.
Competitive Landscape
Smith & Nephew operates in the highly competitive global medical device market. While it maintains a strong, specialized position, it faces significant competition from other large-scale medical technology firms. Key competitors include:
- Johnson & Johnson (JNJ): A massive, diversified global healthcare leader. JNJ competes across almost all of Smith & Nephew's segments, leveraging superior financial scale and a broader corporate distribution network.
- Stryker Corp (SYK): A dominant rival in the orthopaedics and sports medicine space. Stryker is a particularly strong competitor in robotics and digital enabling technologies, often directly challenging Smith & Nephew's footprint in joint reconstruction.
- Zimmer Biomet (ZBH): A direct competitor specifically focused on musculoskeletal healthcare. Zimmer Biomet competes intensely with Smith & Nephew for share in the global hip and knee implant markets, focusing on clinical efficacy and surgical precision.
Strategic Outlook and Innovation
Smith & Nephew is executing a strategy to accelerate top-line growth and drive margin expansion through operational efficiencies. The company is prioritizing investment in its high-growth Sports Medicine and Advanced Wound Management businesses, while continuously enhancing its Orthopaedics portfolio with AI and robotic digital tools. Ongoing efforts include streamlining global manufacturing and R&D to improve agility in responding to evolving market demands for cost-effective, clinically superior outcomes.
Looking ahead, the firm is focused on strengthening its competitive position in both mature and emerging markets. By leveraging its specialized technical expertise and a growing portfolio of smart, robotic-enabled surgical solutions, Smith & Nephew aims to deliver long-term value, balancing the challenges of competitive pricing with the demand for innovative, high-performance medical technology.
| Top 10 Open Interest For Mar 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | QQQ covered calls | 1. | FLY covered calls | |
| 2. | SLV covered calls | 7. | TSLA covered calls | 2. | PL covered calls | |
| 3. | SPY covered calls | 8. | SOFI covered calls | 3. | RCAT covered calls | |
| 4. | EEM covered calls | 9. | EWZ covered calls | 4. | SOC covered calls | |
| 5. | IBIT covered calls | 10. | FXI covered calls | 5. | SMR covered calls | |
Want more examples? SNEX Covered Calls | SNOW Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
